4
Changes in Ownership
Alkermes plc. Filed Acc 0001127602-24-026629
EVP R&D, Chief Medical Officer sold 10,471 shares at $29.53 ($309,169)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Hopkinson Craig C. · EVP R&D, Chief Medical Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-11-06 | Sale : show line 1 in the form 10b5-1 | −10,471 | $29.53 | $309,169 | 99,238 | D |
| Open-market sales · 10,471 sh · avg $29.53 · $309,169 | ||||||
Loading xslF345X05/form4.xml…